Interestingly, while HDAC inhibitors have demonstrated therapeutic potential in treating neurodegenerative diseases like Alzheimer's (He et al. 2023), our results suggest that an alternative therapeutic strategy may be required for AMD. The gene discussed is HDAC9; the disease is neurodegenerative disease.